<DOC>
	<DOCNO>NCT01620853</DOCNO>
	<brief_summary>The purpose study identification chromosomal aberration non-small cell lung cancer ( NSCLC ) . The imaging system intend diagnostic use aid pathologist detection , count classify ALK FISH stain lung sample .</brief_summary>
	<brief_title>Detection Chromosomal Aberrations Non-small Cell Lung Cancer ( NSCLC ) Using Fluorescent Situ Hybridization ( FISH ) ( ALK Test )</brief_title>
	<detailed_description>The ALK Break Apart FISH test detect chromosomal aberration via fluorescence situ hybridization ( FISH ) formalin-fixed paraffin-embedded ( FFPE ) non-small cell lung cancer ( NSCLC ) tissue specimen . The FDA approve ALK kit design detect rearrangement involve ALK gene ( 2p23 ) . Results ALK Kit intend use , conjunction lieu current standard diagnostic procedure , aid pathologist identification patient eligible treatment XALKORIÂ® ( crizotinib ) .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Chromosome Aberrations</mesh_term>
	<mesh_term>Chromosome Disorders</mesh_term>
	<criteria>Well stain slide bright FISH signal Very old slide already bleach</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Non-small cell lung cancer ( NSCLC )</keyword>
	<keyword>ALK probe</keyword>
	<keyword>FISH</keyword>
	<keyword>Chromosomal aberration</keyword>
</DOC>